Lead Qt GUI Engineer - Medical Device Innovation

Brighter Signals; Cincinnati (OH); On-site; USD 140,000 - 190,000; Full time

Job summary

Johnson & Johnson's MedTech Surgery division in Cincinnati seeks a Lead GUI Engineer with 6+ years of C++/Qt/QML experience in a QNX environment. You will design, implement, test, and review GUI software for sophisticated medical devices and collaborate with cross-functional teams to meet regulatory requirements.

The role emphasizes hands-on development, code reviews, and leading feature development from concept through release, in a fast-paced, FDA-regulated setting.

Qualifications

• 6+ years of software development and testing experience.
• 5+ years GUI development using Qt/QML.
• 5+ years of development with C++ on Linux.
• Experience with Agile methodology and software verification.
• Familiarity with QNX or other RTOS is preferred.

Responsibilities

• Design, implement, and test GUI software solutions for sophisticated problems.
• Create specifications and requirements based on clinical and user feedback.
• Develop applications using Qt and C++ in a FDA-regulated environment.
• Be active in design discussions and code reviews.
• Integrate, test, and debug software solutions.
• Lead feature development from concept through release.
• Identify and implement improvements in architecture, design, and implementation.
• Engage cross-functionally to discover novel solutions.

Skills

C++

Qt/QML

Linux

Agile

Unit testing

Event-driven architecture

Shell scripting

Education

BS in CS/CE or equivalent

MS or Associate degree considered

Tools

QNX

Job description

Johnson & Johnson's MedTech Surgery division in Cincinnati seeks a Lead GUI Engineer with 6+ years of C++/Qt/QML experience in a QNX environment. You will design, implement, test, and review GUI software for sophisticated medical devices and collaborate with cross-functional teams to meet regulatory requirements.

The role emphasizes hands-on development, code reviews, and leading feature development from concept through release, in a fast-paced, FDA-regulated setting.